Coronary Syndrome
📧 Sign up to get email alerts when something new happens for Coronary Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Post Acute Cardiac Event Smoking (PACES) Study [NA]
Clinical trial update for the PACES study evaluating smoking-related outcomes after an acute coronary syndrome event.
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: ISGLT2 in Patients Without DM With Acute MI
This completed clinical trial (NCT06903754) investigated an ISGLT2 SGLT2 inhibitor in patients without diabetes with acute myocardial infarc…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients [NA]
This clinical trial update describes an ongoing study evaluating the efficacy of colchicine anti-inflammatory therapy in patients with acute…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Tailoring Post Discharge - Remote Education and Access for Cardiac Health [NA]
This clinical trial update describes a study evaluating remote education and access support after hospital discharge for patients with acute…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin [Phase 4]
Phase 4 trial investigating whether lowering aspirin dose modifies the innate immune response to endotoxin in patients with acute coronary s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: CHIP and Residual Cardiovascular Event Tendency After Smoking Cessation
A completed clinical trial update examining the relationship between clonal hematopoiesis of indeterminate potential (CHIP) and residual car…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Rule Out of ACS in Primary Care Using a Decision Rule for Chest Pain Including Hs-troponin I POCT [NA]
Clinical trial update indicating the study evaluating a decision rule using hs-troponin I point-of-care testing to rule out acute coronary s…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: OPT-CAD Score GUIded Dual ANtiplatelet De-esCalation Time [NA]
Trial NCT06216821 investigates OPT-CAD score-guided de-escalation timing for dual antiplatelet therapy in acute coronary syndrome and is cur…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: SGLT2-inhibitors on PC-AKI
A clinical trial evaluating whether SGLT2 inhibitors influence the risk of post-contrast acute kidney injury in patients with acute coronary…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal Metabolizers [Phase 1]
Phase 1 PK/PD study comparing Vicagrel capsules with Clopidogrel tablets in healthy CYP2C19 normal metabolizers has been completed to charac…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Cerebral Oxygenation and Burst Suppression
A Göteborg University-sponsored clinical trial evaluating cerebral oxygenation and burst suppression has completed. The disease focus includ…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis [Phase 3]
This clinical trial update describes a Phase 3 study evaluating doxycycline as a host-directed therapy to improve lung function and reduce t…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients
Benidipine is being studied in patients with chronic coronary syndrome, hypertension, and angina; the trial is currently enrolling by invita…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Preventive Intervention Value of DCB in Vulnerable Coronary Atherosclerotic Plaques [NA]
Clinical trial update indicates an ongoing study evaluating the preventive value of drug-coated balloons for vulnerable coronary atheroscler…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Role of Frailty in Bleeding Risk Prediction in Acute Coronary Syndrome
A clinical trial by Assiut University aims to determine whether frailty improves bleeding risk prediction in patients with acute coronary sy…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Barts Sex-CAD Database - Sex Hormones and Inflammatory Status in Coronary Artery Disease
Ongoing recruitment for the Barts Sex-CAD Database study examining the relationship between sex hormones and inflammatory status in coronary…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Clinical trial update examining cardiovascular complications in patients undergoing allogeneic hematopoietic stem cell transplantation. The …
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Time for a Diagnostic Paradigm Shift From STEMI/NSTEMI to OMI/NOMI [NA]
This clinical trial update discusses evaluating a diagnostic paradigm shift from STEMI/NSTEMI to OMI/NOMI for acute myocardial infarction an…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Evaluation of Mean Platelet Volume and Systemic Inflammatory Response Index (SIRI) in Patients of Acute Coronary Syndrome
This clinical trial aims to evaluate mean platelet volume and the systemic inflammatory response index (SIRI) in patients with acute coronar…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome [Phase 4]
Phase 4 clinical trial update comparing ticagrelor plus aspirin vs aspirin alone after isolated coronary artery bypass grafting in patients …
-
EMA approval · 2025-08-28EMA Authorised: Rivaroxaban Accord (rivaroxaban) — Accord Healthcare S.L.U.
The EMA authorised Accord Healthcare's rivaroxaban product (Rivaroxaban Accord) for multiple indications including acute coronary syndrome, …
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Inducing and Relieving Factors of Chest Tightness (Pain) in Patients With Acute Coronary Syndrome
This clinical trial update reports on a completed study evaluating factors that induce or relieve chest tightness or chest pain in patients …
-
EMA approval · 2025-08-26EMA Authorised: Iscover (clopidogrel) — Sanofi Winthrop Industrie
The European Medicines Agency has authorised Iscover, a clopidogrel product from Sanofi Winthrop Industrie, for preventing thrombotic events…
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome [Phase 3]
A Phase 3 trial evaluating whether adding inclisiran to usual care reduces LDL-cholesterol in patients with a recent acute coronary syndrome…
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial [Phase 4]
Phase 4 clinical trial update evaluating optimal antiplatelet therapy for patients with acute coronary syndrome at high risk of both bleedin…